Vetoquinol is one of the main international players in animal health for livestock and pets. We’re an independent company, solely focused on innovating, developing, producing, and marketing veterinary drugs and care products globally.
In 2025, our organisation registered a sales revenue of €526 million. This was from 24 countries coming from farm animals and pets. it was all thanks to our established network of over 60 partner distributors.
Since our creation in 1933, Vetoquinol has combined innovation and geographical diversification. The strengthening of our product portfolio – and various acquisitions – has ensured growth for our group. Today, Vetoquinol employs more than 2,486 people.
Vetoquinol’s key figures for 2025:
| 2024 turnover: € 526 million Essential* products turnover: € 334 million | Breakdown of group turnover by activity: Companion animals 70% Farm animals 30% |
* Vetoquinol key products.